» Authors » Chris Drakeley

Chris Drakeley

Explore the profile of Chris Drakeley including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 334
Citations 12498
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Westaway J, Diez Benavente E, Auburn S, Kucharski M, Aranciaga N, Nayak S, et al.
PLoS Negl Trop Dis . 2025 Mar; 19(3):e0012885. PMID: 40072967
Sabah, Malaysia, has amongst the highest burden of human Plasmodium knowlesi infection in the world, associated with increasing encroachment on the parasite's macaque host habitat. However, the genomic make-up of...
2.
de Rezende D, Garcia K, Tauil P, Muller I, Drakeley C, Lacerda M, et al.
Malar J . 2025 Feb; 24(1):57. PMID: 39984907
This report outlines the process of malaria elimination in two municipalities, São Francisco do Sul and Araquari, located in Santa Catarina, Southern Brazil, from 1980 to 1985. Before 1948, Santa...
3.
Nasir Y, Molla E, Habtamu G, Sisay S, Ejigu L, Kassa F, et al.
PLoS Negl Trop Dis . 2025 Feb; 19(2):e0012837. PMID: 39946429
Background: Duffy Binding Protein (PvDBP) binding to the Duffy antigen receptor for chemokine (DARC) is essential for Plasmodium vivax invasion of human reticulocytes. PvDBP copy number variation (CNV) might increase...
4.
Byrne I, Nelli L, Urena K, Desir L, Hilario Rodriguez C, Michelen Strofer N, et al.
Am J Trop Med Hyg . 2025 Jan; PMID: 39836973
As countries strive for malaria elimination, it is crucial to gather sufficient evidence to confirm the absence of transmission. Routine surveillance data often lack the sensitivity to detect community transmission...
5.
Ciavarella C, Drakeley C, Price R, Mueller I, White M
Lancet Infect Dis . 2025 Jan; PMID: 39818221
Background: Plasmodium vivax forms dormant liver stages (hypnozoites) that can reactivate weeks to months after primary infection. Radical cure requires a combination of antimalarial drugs to kill both the blood-stage...
6.
Mahamar A, Vanheer L, Smit M, Sanogo K, Sinaba Y, Niambele S, et al.
Lancet Microbe . 2024 Dec; 6(2):100966. PMID: 39701119
Background: Triple artemisinin-based combination therapies (TACTs) can delay the spread of antimalarial drug resistance. Artesunate-amodiaquine is widely used for uncomplicated Plasmodium falciparum malaria. We therefore aimed to determine the safety...
7.
Bertran-Cobo C, Dumont E, Noordin N, Lai M, Stone W, Tetteh K, et al.
J Infect Dis . 2024 Dec; PMID: 39658124
Background: Malaria remains a major public health concern with substantial morbidity and mortality worldwide. In Malaysia, the emergence of Plasmodium knowlesi has led to a surge in zoonotic malaria cases...
8.
Nelli L, Surendra H, Byrne I, Ahmad R, Arisanti R, Lesmanawati D, et al.
BMJ Glob Health . 2024 Dec; 9(12). PMID: 39645241
Assessing elimination of malaria locally requires a surveillance system with high sensitivity and specificity to detect its presence without ambiguity. Currently, the WHO standard criteria of observing the absence of...
9.
Hutchins H, Pretorius E, Bradley J, Teixeira da Silva E, Vasileva H, Ndiath M, et al.
Lancet Infect Dis . 2024 Nov; PMID: 39551062
Background: Arthropod vectors feeding on the blood of individuals treated with ivermectin have substantially increased mortality. Whether this effect will translate into a useful tool for reducing malaria burden at...
10.
Kamau E, Ante-Testard P, Gwyn S, Blumberg S, Abdalla Z, Aiemjoy K, et al.
medRxiv . 2024 Oct; PMID: 39399026
Trachoma is targeted for global elimination as a public health problem by 2030. Measurement of IgG antibodies in children is being considered for surveillance and programmatic decision-making. There are currently...